Clinical Trial

Clinical Trial Evaluating the Efficacy and Safety of Dexamethasone Compared to Placebo in Patients With Severe Influenza

Study acronym: FLUDEX
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Clinical trial with an active ingredient of a pharmaceutical specialty marketed in Spain vs. placebo. Randomized, double-blind, multicenter phase III clinical trial that evaluates the efficacy and safety of dexamethasone compared to placebo in patients with severe influenza.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-25.
Status change: Withdrawn → Recruiting 2025-02-17
Trial Details
NCT Number NCT06528444
Lead Sponsor Instituto de Investigación Sanitaria y Biomédica de Alicante
Conditions Influenza
Enrollment 42 participants
Start Date 2024-10-01
Primary Completion 2028-10-31 (estimated)
Study Completion 2028-10-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-19